Sotac Pharmaceuticals

Sotac Pharmaceuticals

125.00
+1.05
(0.85%)
Market Cap
138.13 Cr
EPS
7.26
PE Ratio
17.07
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
170.00
52 Week Low
88.05
PB Ratio
2.57
Debt to Equity
0.72
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,733.80
#1 4,15,996.70
35.83
#1 54,729.00
12.06
#1 10,980
-18.99
64.93
6,650.00
1,76,536.61
80.94
9,712.00
0.89
2,191
23.05
46.65
3,730.60
1,26,260.46
63.15
11,539.40
6.99
1,911
19.91
74.11
1,559.40
1,25,953.96
23.58
28,409.50
7.12
5,291
9.88
65.36
1,292.10
1,07,834.93
#1 19.10
33,741.20
16.73
5,725
1.26
55.19
2,575.50
1,06,298.29
60.68
12,744.20
19.57
2,007
-10.91
55.92
995.15
1,00,135.38
21.54
23,511.00
13.82
4,615
-0.19
61.25
1,984.60
90,635.78
27.91
22,909.50
#1 19.94
3,306
#1 112.49
58.19
35,195.00
74,786.92
52.17
6,684.70
10.80
1,414
27.83
60.78
1,158.00
67,256.83
19.47
31,378.10
17.55
3,366
-0.50
55.87
Forecast
Actual
Growth Rate
Revenue Growth
34.06 %
Net Income Growth
56.52 %
Cash Flow Change
-298.03 %
ROE
-37.47 %
ROCE
-56.62 %
EBITDA Margin (Avg.)
-11.58 %

Quarterly Financial Results

Quarterly Financials
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
41
20
18
25
27
26
27
26
28
Expenses
36
18
16
23
25
23
25
23
25
EBITDA
4
2
3
3
2
3
2
3
3
Operating Profit %
9 %
9 %
13 %
9 %
8 %
10 %
4 %
9 %
8 %
Depreciation
1
1
1
1
1
1
1
1
1
Interest
1
0
1
1
1
1
0
0
1
Profit Before Tax
2
1
1
2
1
2
0
1
1
Tax
1
0
0
0
0
1
-1
-0
1
Net Profit
1
1
1
1
1
1
2
2
1
EPS in ₹
4.41
0.29
1.58
1.01
0.58
0.82
1.49
1.32
0.42

Balance Sheet

Balance Sheet
2020
2021
2023
2024
2025
Total Assets
30
35
74
105
124
Fixed Assets
16
17
26
36
47
Current Assets
14
17
47
61
70
Capital Work in Progress
0
0
0
5
0
Investments
0
0
0
0
20
Other Assets
14
18
48
65
0
Total Liabilities
30
35
74
105
124
Current Liabilities
19
23
46
44
52
Non Current Liabilities
6
9
8
12
14
Total Equity
5
3
20
49
53
Reserve & Surplus
1
0
2
34
42
Share Capital
2
2
8
11
11

Cash Flow

Cash Flow
2020
2021
2023
2024
Net Cash Flow
-0
-0
10
-6
Investing Activities
-12
-3
-12
-20
Operating Activities
0
-0
8
-16
Financing Activities
11
3
13
30

Share Holding

% Holding
Apr 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Promoter
72.85 %
72.85 %
72.85 %
72.85 %
72.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.19 %
5.32 %
5.82 %
6.01 %
4.70 %
Others
18.96 %
21.83 %
21.33 %
21.14 %
22.45 %
No of Share Holders
784
255
245
251
243

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 120.65 120.40
29 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Oct 2024 136.80 130.00
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 154.95 135.55

Technical Indicators

RSI(14)
Neutral
48.22
ATR(14)
Less Volatile
4.21
STOCH(9,6)
Oversold
5.47
STOCH RSI(14)
Oversold
7.62
MACD(12,26)
Bearish
-1.37
ADX(14)
Weak Trend
10.86
UO(9)
Bearish
41.51
ROC(12)
Downtrend And Accelerating
-9.55
WillR(14)
Oversold
-96.30